Publication

The effect of financial and educational incentives on rational prescribing: A state-space approach

Pechlivanoglou, P., Wieringa, J. E., de Jager, T. & Postma, M. J., Apr-2015, In : Health Economics. 24, 4, p. 439-453 15 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • The effect of financial and educational incentives on rational prescribing

    Final publisher's version, 430 KB, PDF document

    Request copy

DOI

In 2005, a Dutch health insurer introduced a financial incentive directed to general practitioners to promote rational prescribing of statins and proton pump inhibitors (PPIs). Concomitantly, a regional institution that develops pharmacotherapeutic guidelines implemented two educational interventions also aiming at promoting rational statin and PPI prescribing. Utilizing a prescription database, we estimated the effect of the interventions on drug utilization and cost of statins and PPIs over time. We measured the effect of the interventions within an implementation and a control region. The implementation region included prescriptions from the province of Groningen where the educational intervention was implemented and where the health insurer is most active. The control region comprised all other provinces covered by the database. We modelled the effect of the intervention using a state-space approach. Significant differences in prescribing and cost patterns between regions were observed for statins and PPIs. These differences however were mostly related to the concurrent interventions of Proeftuin Farmacie Groningen. We found no evidence indicating a significant effect of the rational prescribing intervention on the prescription patterns of statins and PPIs. Our estimates on the economic impact of the Proeftuin Farmacie Groningen interventions indicate that educational activities as such can achieve significant cost savings. Copyright © 2014 John Wiley & Sons, Ltd.

Original languageEnglish
Pages (from-to)439-453
Number of pages15
JournalHealth Economics
Volume24
Issue number4
Early online date11-Feb-2014
Publication statusPublished - Apr-2015

    Keywords

  • Drug prescribing, Financial incentives , Health insurers , Kalman filter , State space , The Netherlands , Time Series, hydroxymethylglutaryl coenzyme A reductase inhibitor, statin (protein), proton plump inhibitor, health, Netherlands, time series analysis, prescription, data base, human, cost control, son, general practitioner, drug utilization

View graph of relations

ID: 13839043